Prostate Cancer - Results from #1040

Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial. July 12, 2024

Outcomes after precision prostatectomy: safety, efficacy and transference of skills. July 12, 2024

Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer. July 12, 2024

ProsTAV, a clinically useful test in prostate cancer: an extension study. July 12, 2024

Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality. July 12, 2024

Clinical considerations for sexual and gender minorities with prostate cancer. July 12, 2024

JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway. July 12, 2024

Clinically relevant humanized mouse models of metastatic prostate cancer facilitate therapeutic evaluation. July 12, 2024

CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. July 12, 2024

GE HealthCare’s MIM Software Introduces MIM Symphony HDR Prostate for MR Image Guidance During Procedures July 11, 2024

Dosimetry of [177Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis. July 11, 2024

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution. July 11, 2024

Variants in Vitamin D-related Genes and Prostate Cancer Risk in Black Men. July 11, 2024

Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer. July 11, 2024

A vitamin D-based strategy overcomes chemoresistance in prostate cancer. July 11, 2024

Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer. July 11, 2024

Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes. July 11, 2024

Longer prostate stromal cell telomere length is associated with increased risk of death from other cancers. July 11, 2024

From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer. July 11, 2024

Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer. July 11, 2024

Page 53 of 1458